()
has been a registered insider since 2003.
As Chief Executive Officer at Apellis Pharmaceuticals, last made a transaction on 2/3/2026.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 12 |
33% |
2% |
-3% |
173 |
1 Year |
12 |
0% |
-- |
-- |
-- |
| 12 |
42% |
8% |
-18% |
194 |
9 Month |
12 |
0% |
-- |
-- |
-- |
| 12 |
42% |
-6% |
-23% |
103 |
6 Month |
12 |
0% |
-- |
-- |
-- |
| 12 |
42% |
-6% |
-4% |
121 |
3 Month |
12 |
0% |
-- |
-- |
-- |
| 13 |
62% |
7% |
3% |
111 |
1 Month |
13 |
0% |
-- |
-- |
-- |
| 13 |
69% |
3% |
2% |
56 |
1 Week |
13 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 32 |
50% |
7% |
1% |
179 |
1 Year |
32 |
0% |
-- |
-- |
-- |
| 32 |
53% |
7% |
-6% |
222 |
9 Month |
32 |
0% |
-- |
-- |
-- |
| 35 |
46% |
3% |
2% |
114 |
6 Month |
35 |
0% |
-- |
-- |
-- |
| 35 |
57% |
0% |
-6% |
132 |
3 Month |
35 |
0% |
-- |
-- |
-- |
| 38 |
39% |
5% |
2% |
111 |
1 Month |
38 |
0% |
-- |
-- |
-- |
| 38 |
50% |
1% |
0% |
56 |
1 Week |
38 |
0% |
-- |
-- |
-- |
| Scorecards Updated 3/3/2026 03:48 AM EST |
Latest Transaction Date: |
2/3/2026 |
| Average days between Transaction and Entered Dates: |
2 |
